These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19722894)

  • 21. Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans.
    Borggren M; Nielsen J; Bragstad K; Karlsson I; Krog JS; Williams JA; Fomsgaard A
    Hum Vaccin Immunother; 2015; 11(8):1983-90. PubMed ID: 25746201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Avian influenza vaccines].
    Vasil'ev IuM
    Vopr Virusol; 2008; 53(6):4-15. PubMed ID: 19172900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity.
    Rosendahl Huber SK; Hendriks M; Jacobi RHJ; van de Kassteele J; Mandersloot-Oskam JC; van Boxtel RAJ; Wensing AMJ; Rots NY; Luytjes W; van Beek J
    Front Immunol; 2018; 9():3103. PubMed ID: 30761157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal delivery of protein and DNA vaccines.
    Dean HJ
    Expert Opin Drug Deliv; 2005 Mar; 2(2):227-36. PubMed ID: 16296750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates.
    Koday MT; Leonard JA; Munson P; Forero A; Koday M; Bratt DL; Fuller JT; Murnane R; Qin S; Reinhart TA; Duus K; Messaoudi I; Hartman AL; Stefano-Cole K; Morrison J; Katze MG; Fuller DH
    PLoS One; 2017; 12(12):e0189780. PubMed ID: 29267331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses.
    Fernando GJ; Zhang J; Ng HI; Haigh OL; Yukiko SR; Kendall MA
    J Control Release; 2016 Sep; 237():35-41. PubMed ID: 27381247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine.
    Jazi MH; Dabaghian M; Tebianian M; Gharagozlou MJ; Ebrahimi SM
    Virus Res; 2012 Aug; 167(2):219-25. PubMed ID: 22609252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bystander help within a polyepitope DNA vaccine improves immune responses to influenza antigens.
    Baird M; Wilson R; Young L; Williman J; Young S; Wilson M; Slobbe L; Lockhart E; Buchan G
    Scand J Immunol; 2004 Oct; 60(4):363-71. PubMed ID: 15379861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selecting and Using the Appropriate Influenza Vaccine for Each Individual.
    Sekiya T; Ohno M; Nomura N; Handabile C; Shingai M; Jackson DC; Brown LE; Kida H
    Viruses; 2021 May; 13(6):. PubMed ID: 34073843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection.
    Bragstad K; Vinner L; Hansen MS; Nielsen J; Fomsgaard A
    Vaccine; 2013 Apr; 31(18):2281-8. PubMed ID: 23499598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current status and progress of prepandemic and pandemic influenza vaccine development.
    Leroux-Roels I; Leroux-Roels G
    Expert Rev Vaccines; 2009 Apr; 8(4):401-23. PubMed ID: 19348557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subunit vaccines based on recombinant yeast protect against influenza A virus in a one-shot vaccination scheme.
    Gebauer M; Hürlimann HC; Behrens M; Wolff T; Behrens SE
    Vaccine; 2019 Sep; 37(37):5578-5587. PubMed ID: 31399274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of seasonal pandemic influenza hemagglutinin DNA vaccines delivered by electroporation against a seasonal H1N1 virus challenge in mice.
    Tan L; Lu H; Zhang D; Wang K; Tian M; Liu C; Liu Y; Hu B; Jin N
    Sci China Life Sci; 2011 Apr; 54(4):293-9. PubMed ID: 21416231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
    Smith LR; Wloch MK; Ye M; Reyes LR; Boutsaboualoy S; Dunne CE; Chaplin JA; Rusalov D; Rolland AP; Fisher CL; Al-Ibrahim MS; Kabongo ML; Steigbigel R; Belshe RB; Kitt ER; Chu AH; Moss RB
    Vaccine; 2010 Mar; 28(13):2565-72. PubMed ID: 20117262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza vaccines: new developments.
    Rimmelzwaan GF; Osterhaust AD
    Curr Opin Pharmacol; 2001 Oct; 1(5):491-6. PubMed ID: 11764775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice.
    Scott VL; Patel A; Villarreal DO; Hensley SE; Ragwan E; Yan J; Sardesai NY; Rothwell PJ; Extance JP; Caproni LJ; Weiner DB
    Hum Vaccin Immunother; 2015; 11(8):1972-82. PubMed ID: 26091432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine approaches conferring cross-protection against influenza viruses.
    Vemula SV; Sayedahmed EE; Sambhara S; Mittal SK
    Expert Rev Vaccines; 2017 Nov; 16(11):1141-1154. PubMed ID: 28925296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.